Donaldson Translational Fellows Program

The Program, made possible by generous support from the Oliver S. and Jennie R. Donaldson Charitable Trust, is focused on removing historical barriers between research and medicine to accelerate the application of discoveries to benefit patients.

Donaldson Fellows are graduates with Ph.D., M.D., or M.D./Ph. D. who have completed the bulk of their clinical training, or have extensive experience in translational research. Successful candidates will conduct translational research jointly at CSHL, usually in cancer, quantitative biology, or neuroscience, along with clinical partners. Drawing on the expertise of CSHL faculty and collaborative scientists, Donaldson Fellows pursue the discovery and development of novel therapeutic and diagnostic strategies, while working with leading clinicians toward the development of early-phase clinical trials (typically phase 0 – phase I) to confirm their findings in patients, and to relate clinical findings back to the laboratory. Donaldson Fellowships will be for a period of 2 years with an option to renew for a third year.

If you are interested in the program, please contact Dave Tuveson M.D., Ph.D. at tuveson@cshl.edu or by telephone at 516-734-5246 for more information.

Dr. Sandeep Nadella, M.D., Ph.D.
August 2021-Current

Dr. Fieke Froeling, M.D., Ph.D., MRCP
October 2017 to August 2020

Professor Semir Beyaz, Ph.D.
December 2017- 2022